LivaNova PLC (NASDAQ:LIVN) Short Interest Down 18.6% in February

LivaNova PLC (NASDAQ:LIVN) was the recipient of a significant decline in short interest in the month of February. As of February 28th, there was short interest totalling 1,580,000 shares, a decline of 18.6% from the February 13th total of 1,940,000 shares. Currently, 2.9% of the company’s shares are sold short. Based on an average trading volume of 613,400 shares, the short-interest ratio is currently 2.6 days.

Wall Street Analysts Forecast Growth

LIVN has been the subject of a number of research analyst reports. Wolfe Research cut LivaNova from an “outperform” rating to a “peer perform” rating in a research note on Wednesday, February 26th. StockNews.com lowered LivaNova from a “strong-buy” rating to a “buy” rating in a report on Wednesday, February 26th. Barclays dropped their target price on LivaNova from $58.00 to $56.00 and set an “equal weight” rating on the stock in a report on Friday, March 7th. Stifel Nicolaus dropped their price objective on LivaNova from $72.00 to $60.00 and set a “buy” rating on the stock in a research note on Wednesday, February 26th. Finally, The Goldman Sachs Group lowered their target price on LivaNova from $64.00 to $55.00 and set a “buy” rating on the stock in a research note on Monday, March 3rd. Two investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $61.17.

Institutional Investors Weigh In On LivaNova

Large investors have recently added to or reduced their stakes in the stock. Russell Investments Group Ltd. boosted its holdings in shares of LivaNova by 17.1% in the 4th quarter. Russell Investments Group Ltd. now owns 1,502 shares of the company’s stock valued at $70,000 after purchasing an additional 219 shares in the last quarter. Sterling Capital Management LLC lifted its stake in shares of LivaNova by 800.6% in the 4th quarter. Sterling Capital Management LLC now owns 1,621 shares of the company’s stock valued at $75,000 after acquiring an additional 1,441 shares during the last quarter. Central Pacific Bank Trust Division lifted its stake in shares of LivaNova by 21.2% in the 4th quarter. Central Pacific Bank Trust Division now owns 4,117 shares of the company’s stock valued at $191,000 after acquiring an additional 720 shares during the last quarter. Vestcor Inc bought a new position in shares of LivaNova in the 4th quarter valued at $204,000. Finally, Optimize Financial Inc bought a new position in shares of LivaNova in the 4th quarter valued at $208,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

LivaNova Price Performance

NASDAQ:LIVN traded up $0.43 during trading hours on Wednesday, reaching $40.84. 706,127 shares of the company were exchanged, compared to its average volume of 601,254. The company has a market capitalization of $2.22 billion, a P/E ratio of 97.24 and a beta of 1.10. LivaNova has a 1-year low of $36.85 and a 1-year high of $64.48. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.37 and a quick ratio of 2.87. The business has a 50 day moving average of $45.75 and a 200 day moving average of $48.94.

About LivaNova

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.